Abstract

1.0 Introduction

Epigenetic modifications have been described as heritable changes in gene activity that occur without changes to DNA sequence, and this regulatory layer has been implicated in a wide array of physiological and pathological states, particularly in immune regulation and autoimmune disease pathogenesis. Epigenetics encompasses DNA methylation, histone modifications, and non-coding RNA mechanisms, but DNA methylation has emerged as one of the most studied processes connected to autoimmune conditions because of its direct influence on gene expression, immune cell identity, and response to environmental stimuli. DNA methylation typically occurs at cytosine–guanine (CpG) dinucleotides and can repress gene transcription when present in gene promoters or enhancers, a mechanism thought to underlie altered gene expression profiles observed in autoimmune phenotypes. Researchers have noted that epigenetic changes often integrate genetic susceptibility and environmental exposures such as smoking, infection, and diet which are established risk factors for diseases like rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and multiple sclerosis (MS). Historically, autoimmune diseases are characterised by dysregulated immune responses against self-antigens, and while genome-wide association studies (GWAS) have identified multiple susceptibility loci, these genetic variants only partially account for disease heritability. Epigenetic studies emerged to bridge this gap by probing how gene regulation shaped by methylation and immune cell lineage commitment may influence disease onset and progression. For instance, early investigations in RA patients identified distinct methylation changes in T and B cells compared to healthy counterparts, suggesting that immune cell hyperactivity could be influenced by underlying epigenetic states that either promote or restrain transcriptional programs involved in inflammation and autoimmunity . Moreover, global hypomethylation patterns, often associated with greater transcriptional plasticity, have been reported in autoimmune settings, supporting the concept that epigenetic dysregulation fuels aberrant immune responses .

The central goal of this paper is to present a comparative analysis of epigenetic modifications with particular emphasis on methylation haplotypes across multiple autoimmune diseases. Methylation haplotypes are patterns of methylation at adjacent CpG sites that collectively reflect regulatory states, potentially enhancing disease association signals beyond single CpG analyses. This multi-locus approach offers greater resolution in linking epigenetic patterns to disease susceptibility and mechanisms, especially in autoimmune disorders where small changes in immune regulation can have profound effects. By integrating data from rheumatoid arthritis and its comparison with other autoimmune profiles, this study aims to address how methylation patterns correlate with disease risk, immune activation signatures, and clinical features. The theoretical framework guiding this study asserts that epigenetic regulation represents an interface between innate genetic predisposition and environmental exposures, offering a dynamic yet stable mechanism that can propagate disease risk across cell divisions. The two primary theories that underlie this framework are the gene-environment interaction theory and the epigenetic drift model. The gene-environment interaction theory argues that epigenetic modifications mediate the effects of environmental triggers (e.g., smoking or infections) on genetically susceptible individuals, thus facilitating autoimmune disease onset. Indeed, certain methylation patterns have been shown to shift based on environmental factors and correlate with clinical severity in RA patients. The epigenetic drift model posits progressive changes in epigenetic patterns over time, potentially affecting immune tolerance and contributing to age-related increases in autoimmune incidence. By situating methylation haplotypes within these theoretical contexts, the paper interprets differential methylation patterns as not only biomarkers of disease but also mechanistically relevant regulators of immune dysregulation. This paper bridges mechanistic insights with disease biomarkers, offering a foundation for predictive models and potential therapeutic targets grounded in epigenetic regulation.